Joel Dunn

Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL

N. George Mikhaeel, Daniel Smith, Joel Dunn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 312 citations · Full text

Medicine, Biostatistics, Oncology +17

Attenuation of Insulin-Evoked Responses in Brain Networks Controlling Appetite and Reward in Insulin Resistance

Karen Anthony, Laurence Reed, Joel Dunn et al. · Diabetes · 2006 · 192 citations · Full text

Medicine, Endocrinology, Neuroscience +16

[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1

Victoria Warbey, Rosalie E. Ferner, Joel Dunn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 155 citations

Medicine, Neurology, Oncology +13

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma

Hajira Ilyas, N. George Mikhaeel, Joel Dunn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 150 citations · Full text

Medicine, Oncology, Oncologic Imaging +9

Attenuation of Amydgala and Frontal Cortical Responses to Low Blood Glucose Concentration in Asymptomatic Hypoglycemia in Type 1 Diabetes

Joel Dunn, Iain Cranston, Paul Marsden et al. · Diabetes · 2007 · 80 citations · Full text

Medicine, Neurology, Neuroscience +16